Contact menu close close AI platform Our team Testimonials Contact us info@cancierge.ai About us Home Benefits For whom

Individualized therapeutic approaches for clinics and patients arrow_downward AI decision support for breast cancer

Learn more Learn more Treat breast cancer effectively.
Increase survival rates. Treat breast cancer effectively.
Increase survival rates. About us Wer wir sind Wer wir sind Effective breast cancer treatment.
Increased life time. Knowledge that can save lives often remains the preserve of a few experts. cancierge® makes this knowledge accessible. Clinics are often unable to implement the multitude of new national and international guidelines, studies, and findings due to a lack of time and resources. cancierge® prepares scientific findings on a case-by-case basis and enables patients to evaluate them together with their treating physician in an individual context.

About cancierge
To achieve this, we combine clinical data with oncological expertise to develop an AI-supported platform that assists oncologists in making informed, individualized treatment decisions and offers patients greater guidance throughout the course of treatment. AI platform for tailored support in choosing breast cancer treatment – developed with key opinion leaders. For clinics More efficient tumor conferences. Better decisions.
 AI-supported, case-related therapy information to support individual treatment decisions
Targeted support for more structured and faster decision-making processes in tumor conferences
Relief for the medical and healthcare team For patients Reliable guidance – anytime, anywhere in the world. Individual information on treatment options based on personal medical data
Comprehensible presentation of medical content for discussion with your doctor
Greater guidance and certainty when making upcoming treatment decisions

About cancierge
To achieve this, we combine clinical data with oncological expertise to develop an AI-supported platform that assists oncologists in making informed, individualized treatment decisions and offers patients greater guidance throughout the course of treatment. AI platform for tailored support in choosing breast cancer treatment – developed with key opinion leaders. For clinics More efficient tumor conferences. Better decisions.
 AI-supported, case-related therapy information to support individual treatment decisions
Targeted support for more structured and faster decision-making processes in tumor conferences
Relief for the medical and healthcare team For patients Reliable guidance – anytime, anywhere in the world. Individual information on treatment options based on personal medical data
Comprehensible presentation of medical content for discussion with your doctor
Greater guidance and certainty when making upcoming treatment decisions

Your health in best hands Our AI helps you make informed treatment decisions. New approaches to cancer treatment Supporting therapy decisions Current scientific findings, combined with patient data, form the basis for structured and evidence-based treatment options.
 Combination of research, practice, and technology Findings from studies, clinical experience, and AI are continuously incorporated into the decision-making logic. Cancierge® uses AI-powered analytics to provide faster and more informed individualized treatment options. For clinics and patients.
 Data security as a fundamental principle
 All medical data is processed in compliance with the GDPR and protected by state-of-the-art infrastructure and security technologies.


Evidence-based
therapy decisions 01 Supporting patients 02 Optimal use of clinical data 03 Individual recommendations for each case 04 High satisfaction among professionals 05 Round-the-clock support 06

Daniel Rüben Founder & CEO Daniel is a seasoned entrepreneur with a track record of building, merging, and selling software companies, including a recent sale to a Nasdaq-listed company. His leadership drives the strategic vision of Cancierge.ai, guiding our growth and market expansion. Prof. Dr. med. Sherko Kümmel Prof. Dr. Sherko Kümmel is a renowned specialist in breast cancer and heads the Clinic for Gynecology and the BreastCenter in Essen—one of Europe’s leading centers, recognized by the German Cancer Society and designated by the state of North Rhine-Westphalia as a surgical treatment center. With several top awards in breast cancer surgery and treatment, Prof. Dr. Kümmel brings invaluable clinical expertise and acts as a key validator in the development of Cancierge to ensure that our product meets the highest medical standards. Our team of experts meet the entire team for every specialty meet the entire team Prof. Peter Schmid Peter Schmid, Chair of Cancer Medicine at Queen Mary University of London, is a world-leading breast cancer oncologist and lead author of New England Journal of Medicine studies that have redefined standards in triple-negative breast cancer. Founder & Medical Lead Medical Lead

Creating impact on people´s lives. Creating impact Creating impact on people´s lives. cancierge® on people´s lives. Creating impact on people´s lives. The mind is everything. Creating impact
 on people´s lives. cancierge® What you think you become.

Testimonials

Discover how cancierge® is transforming cancer treatment

The treatment decisions made by the AI are excellent! When can we start using the product in our clinic?

Anna during validation and testing sessions with our product team

Dr. med. Anna Rühland
Leiterin der Brustzentrum-Sektion, leitende Oberärztin
Fachärztin für Gynäkologie & Geburtshilfe

keyboard_arrow_rightContact us Links keyboard_arrow_rightAbout us AI decision support & deep-medicine for cancer treatment info@cancierge.ai keyboard_arrow_rightFor whom keyboard_arrow_rightBenefits keyboard_arrow_rightAI platform keyboard_arrow_rightOur team keyboard_arrow_rightTestimonials 2026 cancierge. All rights reserved. Data policy Imprint
de_DEen_US